Literature DB >> 19105223

Gene targeted ablation of high molecular weight fibroblast growth factor-2.

Mohamad Azhar1, Moying Yin, Ming Zhou, Hongqi Li, Marwan Mustafa, Eyad Nusayr, Jack B Keenan, Hwudaurw Chen, Sharon Pawlosky, Connie Gard, Christina Grisham, L Philip Sanford, Tom Doetschman.   

Abstract

Fibroblast growth factor-2 (FGF2) is produced as high molecular weight isoforms (HMW) and a low molecular weight isoform (LMW) by means of alternative usage of translation start sites in a single Fgf2 mRNA. Although the physiological function of FGF2 and FGF2 LMW has been investigated in myocardial capillarogenesis during normal cardiac growth, the role of FGF2 HMW has not been determined. Here, we report the generation of FGF2 HMW-deficient mice in which FGF2 HMW isoforms are ablated by the Tag-and-Exchange gene targeting technique. These mice are normal and fertile with normal fecundity, and have a normal life span. Histological, immunohistochemical, and morphometric analyses indicate normal myocardial architecture, blood vessel, and cardiac capillary density in young adult FGF2 HMW-deficient mice. These mice along with the FGF2- and FGF2 LMW-deficient mice that we have generated previously will be very useful for elucidating the differential functions of FGF2 isoforms in pathophysiology of cardiovascular diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19105223      PMCID: PMC2649784          DOI: 10.1002/dvdy.21835

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  29 in total

1.  Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation.

Authors:  A Montero; Y Okada; M Tomita; M Ito; H Tsurukami; T Nakamura; T Doetschman; J D Coffin; M M Hurley
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

2.  Impaired osteoclast formation in bone marrow cultures of Fgf2 null mice in response to parathyroid hormone.

Authors:  Yosuke Okada; Aldemar Montero; Xuxia Zhang; Takanori Sobue; Joseph Lorenzo; Thomas Doetschman; J Douglas Coffin; Marja M Hurley
Journal:  J Biol Chem       Date:  2003-03-28       Impact factor: 5.157

3.  Basic fibroblast growth factor (Fgf2) is necessary for cell proliferation and neurogenesis in the developing cerebral cortex.

Authors:  R Raballo; J Rhee; R Lyn-Cook; J F Leckman; M L Schwartz; F M Vaccarino
Journal:  J Neurosci       Date:  2000-07-01       Impact factor: 6.167

4.  Overexpression of FGF-2 increases cardiac myocyte viability after injury in isolated mouse hearts.

Authors:  F Sheikh; D P Sontag; R R Fandrich; E Kardami; P A Cattini
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-03       Impact factor: 4.733

5.  Role of fibroblast growth factor-2 isoforms in the effect of estradiol on endothelial cell migration and proliferation.

Authors:  B Garmy-Susini; E Delmas; P Gourdy; M Zhou; C Bossard; B Bugler; F Bayard; A Krust; A C Prats; T Doetschman; H Prats; J F Arnal
Journal:  Circ Res       Date:  2004-04-08       Impact factor: 17.367

6.  Cardiac-specific overexpression of fibroblast growth factor-2 protects against myocardial dysfunction and infarction in a murine model of low-flow ischemia.

Authors:  Stacey L House; Craig Bolte; Ming Zhou; Thomas Doetschman; Raisa Klevitsky; Gilbert Newman; Jo El J Schultz
Journal:  Circulation       Date:  2003-12-01       Impact factor: 29.690

7.  Alternative initiation of translation determines cytoplasmic or nuclear localization of basic fibroblast growth factor.

Authors:  B Bugler; F Amalric; H Prats
Journal:  Mol Cell Biol       Date:  1991-01       Impact factor: 4.272

8.  Signaling via the Tgf-beta type I receptor Alk5 in heart development.

Authors:  Somyoth Sridurongrit; Jonas Larsson; Robert Schwartz; Pilar Ruiz-Lozano; Vesa Kaartinen
Journal:  Dev Biol       Date:  2008-08-07       Impact factor: 3.582

Review 9.  Biological functions of the low and high molecular weight protein isoforms of fibroblast growth factor-2 in cardiovascular development and disease.

Authors:  Siyun Liao; Janet Bodmer; Daniel Pietras; Mohamad Azhar; Tom Doetschman; Jo El J Schultz
Journal:  Dev Dyn       Date:  2009-02       Impact factor: 3.780

10.  Targeted disruption of the Fgf2 gene does not affect vascular growth in the mouse ischemic hindlimb.

Authors:  Chris J Sullivan; Thomas Doetschman; James B Hoying
Journal:  J Appl Physiol (1985)       Date:  2002-08-16
View more
  15 in total

Review 1.  Cardiac-specific inducible and conditional gene targeting in mice.

Authors:  Thomas Doetschman; Mohamad Azhar
Journal:  Circ Res       Date:  2012-05-25       Impact factor: 17.367

2.  Quantitative phosphoproteomics using acetone-based peptide labeling: method evaluation and application to a cardiac ischemia/reperfusion model.

Authors:  Aruna B Wijeratne; Janet R Manning; Jo El J Schultz; Kenneth D Greis
Journal:  J Proteome Res       Date:  2013-09-24       Impact factor: 4.466

3.  The influence of FGF2 high molecular weight (HMW) isoforms in the development of cardiac ischemia-reperfusion injury.

Authors:  Siyun Liao; Janet R Bodmer; Mohamad Azhar; Gilbert Newman; J Douglas Coffin; Thomas Doetschman; Jo El J Schultz
Journal:  J Mol Cell Cardiol       Date:  2010-01-29       Impact factor: 5.000

4.  Knockout of nuclear high molecular weight FGF2 isoforms in mice modulates bone and phosphate homeostasis.

Authors:  Collin Homer-Bouthiette; Thomas Doetschman; Liping Xiao; Marja M Hurley
Journal:  J Biol Chem       Date:  2014-11-11       Impact factor: 5.157

5.  Homeobox, Wnt, and Fibroblast Growth Factor Signaling is Augmented During Alveogenesis in Mice Lacking Superoxide Dismutase 3, Extracellular.

Authors:  Tania A Thimraj; Rahel L Birru; Ankita Mitra; Holger Schulz; George D Leikauf; Koustav Ganguly
Journal:  Lung       Date:  2017-02-20       Impact factor: 2.584

6.  Ablation of low-molecular-weight FGF2 isoform accelerates murine osteoarthritis while loss of high-molecular-weight FGF2 isoforms offers protection.

Authors:  Patience M Burt; Liping Xiao; Thomas Doetschman; Marja M Hurley
Journal:  J Cell Physiol       Date:  2018-08-25       Impact factor: 6.384

7.  Low molecular weight fibroblast growth factor-2 signals via protein kinase C and myofibrillar proteins to protect against postischemic cardiac dysfunction.

Authors:  Janet R Manning; Sarah O Perkins; Elizabeth A Sinclair; Xiaoqian Gao; Yu Zhang; Gilbert Newman; W Glen Pyle; Jo El J Schultz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-03-11       Impact factor: 4.733

8.  Generation of mice with a conditional allele for transforming growth factor beta 1 gene.

Authors:  Mohamad Azhar; Moying Yin; Ramireddy Bommireddy; John J Duffy; Junqi Yang; Sharon A Pawlowski; Gregory P Boivin; Sandra J Engle; L P Sanford; Christina Grisham; Ram R Singh; George F Babcock; Thomas Doetschman
Journal:  Genesis       Date:  2009-06       Impact factor: 2.487

9.  Inhibition of FGFR Signaling Partially Rescues Osteoarthritis in Mice Overexpressing High Molecular Weight FGF2 Isoforms.

Authors:  Liping Xiao; Donyell Williams; Marja M Hurley
Journal:  Endocrinology       Date:  2020-01-01       Impact factor: 4.736

10.  Phosphoproteomic analysis identifies phospho-Threonine-17 site of phospholamban important in low molecular weight isoform of fibroblast growth factor 2-induced protection against post-ischemic cardiac dysfunction.

Authors:  Janet R Manning; Aruna B Wijeratne; Brian B Oloizia; Yu Zhang; Kenneth D Greis; Jo El J Schultz
Journal:  J Mol Cell Cardiol       Date:  2020-08-25       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.